|
KIAA0528 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.4531999999986E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.81172000000007E-05 |
| Normal-vs-Stage2 |
2.515800E-02 |
| Normal-vs-Stage3 |
1.639020E-04 |
| Normal-vs-Stage4 |
2.376700E-03 |
| Stage1-vs-Stage2 |
4.965600E-01 |
| Stage1-vs-Stage3 |
5.307000E-01 |
| Stage1-vs-Stage4 |
6.058400E-01 |
| Stage2-vs-Stage3 |
2.814400E-01 |
| Stage2-vs-Stage4 |
3.725000E-01 |
| Stage3-vs-Stage4 |
9.108400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.85120000000461E-05 |
| Normal-vs-AfricanAmerican |
5.481300E-03 |
| Normal-vs-Asian |
9.562000E-03 |
| Caucasian-vs-AfricanAmerican |
3.801000E-01 |
| Caucasian-vs-Asian |
6.669000E-01 |
| AfricanAmerican-vs-Asian |
4.202400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.3836999999971E-05 |
| Normal-vs-Female |
4.818400E-03 |
| Male-vs-Female |
3.027200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.551200E-04 |
| Normal-vs-Extreme_Weight |
3.94200000000122E-05 |
| Normal-vs-Obese |
8.220600E-04 |
| Normal-vs-Extreme_Obese |
7.381900E-04 |
| Normal_Weight-vs-Extreme_Weight |
8.871600E-01 |
| Normal_Weight-vs-Obese |
4.153400E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.250400E-01 |
| Extreme_Weight-vs-Obese |
2.982800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.283400E-01 |
| Obese-vs-Extreme_Obese |
3.006400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.011700E-02 |
| Normal-vs-Age(41-60Yrs) |
2.781600E-03 |
| Normal-vs-Age(61-80Yrs) |
2.01489999999138E-05 |
| Normal-vs-Age(81-100Yrs) |
6.49750000000227E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.283600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.090000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.280200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.803800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.576400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.199200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.082300E-03 |
| Normal-VS-Type2 PRCC |
6.79389999813651E-08 |
| Normal-VS-KIRP CIMP |
1.391600E-04 |
| Normal-VS-Unclassified PRCC |
1.167620E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.598900E-04 |
| Type1 PRCC-VS-KIRP CIMP |
5.073900E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
7.232600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.542200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.679500E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.243020E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.06420000004037E-06 |
| Normal-vs-N1 |
1.781780E-02 |
| Normal-vs-N2 |
6.355700E-03 |
| N0-vs-N1 |
1.199830E-01 |
| N0-vs-N2 |
6.760400E-01 |
| N1-vs-N2 |
3.026200E-01 |
|
|
